ASLN - ASLAN Pharmaceuticals Limited

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Sep 2018)Next qtr. (Dec 2018)Current year (2018)Next year (2019)
No. of analysts3323
Avg. Estimate-0.33-0.44-1.49-1.11
Low estimate-0.35-0.57-1.56-1.74
High estimate-0.3-0.37-1.42-0.29
Year ago EPSN/AN/AN/A-1.49
Revenue estimateCurrent qtr. (Sep 2018)Next qtr. (Dec 2018)Current year (2018)Next year (2019)
No. of analysts4445
Avg. EstimateN/AN/AN/A9.35M
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/A46M
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings historyInvalid DateInvalid DateInvalid Date29/06/2018
Est. EPSN/AN/AN/A-0.31
Actual EPSN/AN/AN/A-0.35
DifferenceN/AN/AN/A-0.04
Surprise %N/AN/AN/A-12.90%
EPS trendCurrent qtr. (Sep 2018)Next qtr. (Dec 2018)Current year (2018)Next year (2019)
Current estimate-0.33-0.44-1.49-1.11
7 days ago-0.34-0.44-1.49-1.06
30 days ago-0.34-0.44-1.49-1.06
60 days ago-0.34-0.44-1.49-1.04
90 days ago-0.34-0.44-1.49-1.04
EPS revisionsCurrent qtr. (Sep 2018)Next qtr. (Dec 2018)Current year (2018)Next year (2019)
Up last 7 days211N/A
Up last 30 days2111
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1212
Growth estimatesASLNIndustrySectorS&P 500
Current qtr.N/AN/AN/A0.48
Next qtr.N/AN/AN/A0.40
Current yearN/AN/AN/A0.21
Next year25.50%N/AN/A0.10
Next 5 years (per annum)N/AN/AN/A0.11
Past 5 years (per annum)N/AN/AN/AN/A